Trial Site Detail


Nivolumab + BMS-986016
Safety Study of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors
Conditions: Solid Tumors
Trial Status:
Active, not recruiting


Dana Farber Cancer Institute

450 Brookline Ave     
Boston , MA 02215-5450


Principal Investigator:
F. Stephen Hodi, Site 0001 617-582-7603
Activation Status of this Site:
Notes about this Site:
Dana Farber Cancer Institute Website:



Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.